Cancer BiologybioRxiv
Evolution of resistance to Irinotecan in cancer cells involves generation of topoisomerase-guided mutations in non-coding genome that reduce the chances of DNA breaks
S. Kumar, V. Gahramanov, S. Patel…·M. Y. Sherman
The paper investigates how cancer cells develop resistance to irinotecan by generating topoisomerase-guided mutations in non-coding regions, reducing DNA breaks and increasing drug resistance.
DOI 10.3390/ijms24108717